1Cell.Ai Named Best Healthtech Startup 2026

Recognised for Innovation in Precision Oncology & Patient Impact

x

    Request a Callback

    Fill in your details and our team will get in touch with you.


    1Cell.ai Featured in BioSpectrum Asia’s Analysis on AI-Accelerated Cancer Diagnostics

    BioSpectrum Asia, one of Asia’s leading life sciences and biotech publications, featured 1Cell.ai in an industry analysis piece on how AI is transforming cancer diagnostics across the region. We were highlighted for our application of AI to single-cell analysis for detecting circulating tumour cells from blood samples, recognising our platform as one of the key innovations driving early diagnosis and disease monitoring in the precision oncology space. 

    Read the full article

    Related Articles

    1Cell.Ai
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.